Analysis for the year 2019 (Ending December 31, 2019) (Revise Template) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on

15 May 2020 Subject : Management Discussion and Analysis for the First quarter of 2020 (Ending 31 March 2020) To : Managing Director The Stock Exchange of Thailand Getabec Public Company Limited

No. INGRS059 14 September 2020 Subject : Management Discussion & Analysis (MD&A) for the consolidated financial statements of the 2nd quarter ended 31 July 2020 To : The President The Stock Exchange

No. INGRS066 30 March 2021 Subject : Management Discussion & Analysis (MD&A) for the consolidated financial statements for the financial year ended 31 January 2021 To : The President The Stock

-9320 1 Ref: PCL 2020/011 May 11, 2020 Subject: Management Discussion and Analysis for the 3-month period ended 31 March 2020 To: The President of the Stock Exchange of Thailand Panjawattana Plastic

November 13, 2006 May 15, 2020 Subjects : Clarification of Operating Performance for the Q1/2020 Attention : The Director and Manager of the Stock Exchange of Thailand The Consolidated net profit of

-TRANSLATION- 14 August 2020 Subject : Management Discussion and Analysis for Q2/2020 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in

1 No. KK ELCID 2563/003 November 11, 2020 Subject: Management Discussion and Analysis for the third quarter ended September 30, 2020 To: President The Stock Exchange of Thailand K&K Superstore

the 3rd quarter ended 30 September 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 3rd quarter ended 30 September 2019, as submitted by

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech